Can one extra stitch in pancreatic surgery get patients eating again sooner?
NCT ID NCT05709197
First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time
Summary
This trial tests whether adding a Braun anastomosis, an extra connection between two parts of the small intestine, during standard pancreatic surgery helps prevent delayed gastric emptying. Delayed gastric emptying is a common complication where the stomach is slow to empty food, keeping patients from eating normally after surgery. The study enrolls adults undergoing an open pancreatic head resection, also known as a Whipple procedure, and randomly assigns them to receive either the standard reconstruction alone or with the extra Braun anastomosis. Researchers will compare how often delayed gastric emptying occurs in each group to see if the added step makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Braun anastomosis, an extra surgical connection between two loops of the small intestine added during pancreatic surgery
- What this could lead to
- If it works, this extra surgical step could become a standard part of pancreatic surgery, helping patients recover faster and leave the hospital sooner after a Whipple procedure.
- What could go wrong
- The trial is still testing the idea, and the extra connection may not reduce delayed gastric emptying. Surgery carries risks like bleeding, infection, or leakage at the new connection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
256 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Undergoing open pancreatoduodenectomy * Provided informed consent * Age over 18 years Exclusion Criteria: * Insufficient control of the Dutch language to read the patient information and to fill out the questionnaires in Dutch hospitals * Previous bariatric surgery (such as Roux-en-Y gastric bypass, gastric sleeve) * Pregnancy * Bowel motility disorders * Minimally invasive pancreatoduodenectomy * Gastric outlet syndrome
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Delayed gastric emptying are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam UMC
Amsterdam, Netherlands
-
Catharina hospital
Eindhoven, Netherlands
-
Erasmus MC
Rotterdam, Netherlands
-
Groningen UMC
Groningen, Netherlands
-
Isala hospital
Zwolle, Netherlands
-
LUMC
Leiden, Netherlands
-
Maastricht UMC+
Maastricht, Netherlands
-
Medical center Leeuwarden
Leeuwarden, Netherlands
-
Medical spectrum Twente
Enschede, Netherlands
-
OLVG
Amsterdam, Netherlands
-
Radboud UMC
Nijmegen, Netherlands
-
St Antonius hospital
Nieuwegein, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Effect of resuscitation on gastric emptying by gastric residual volume assessment using point of care ultrasonography in pediatric trauma patients
- Can a pill duo outsmart a Hard-to-Treat pancreatic cancer mutation?
- Can a new drug combo outsmart RAS-Mutated pancreatic cancer?
- Can genes and environment together trigger pancreatic disease? a new biobank seeks answers
- Can protein patterns in stored tumors point to new treatment targets?
- Can a triple therapy shrink pancreatic tumors enough for complete surgery?